ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Another example of effective gene silencing was put forward by Vinhas et al. that combined gene silencing via a AuNP loaded with an ASO targeting BCR-ABL1 and imatinib, enhancing cell death in chronic myeloid leukemia (CML) cells [141].